Circio Holding ASA (OB: CRNA)
Health Care · Biotechnology · NO
Nkr11.14
+4.11% today · +522.3% 1Y
Circio Holding ASA (OB: CRNA) operates in the Biotechnology industry within the Health Care sector. The company is valued at $319.79M and employs 10 people.
Over the last twelve months the share price has gained 522.3%, trading between 0.87 and 15.70.
Tweenvest scores Circio Holding ASA across four factors: quality 34/100, value 92/100. Its strongest factor is value.
CRNA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $319.79M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.39
- Dividend yield
- —
- Beta (5Y)
- -1.04
- 52-week high
- Nkr15.70
- 52-week low
- Nkr0.87
- Avg volume (3M)
- —
- Shares outstanding
- 274.63M
- Employees
- 10
- Next earnings
- —
About Circio Holding ASA
Circio Holding ASA, a biotechnology firm based in Oslo, Norway, and founded in 2010, specializes in the development of advanced circular RNA and immunotherapy treatments. Among its key innovations is TG01, a cancer vaccine aimed at specific driver mutations, which is currently progressing through three clinical trials for indications including multiple myeloma, pancreatic cancer, and lung cancer. The company also pioneers the circVec circRNA vector platform, an adaptable genetic module designed to facilitate the creation of diverse functional circular RNAs within human cells. This circVec platform is further supported by a collaborative agreement with Certest Biotec, S.L., focusing on its formulation. Formerly known as Targovax ASA, the company officially rebranded to Circio Holding ASA in May 2023.
- ISIN
- NO0013033795
- Founded
- 2010
- Listed since
- Jul 8, 2016
- Exchange
- Oslo Bors
- Currency
- NOK
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| 3-D Matrix, Ltd.TSE: 7777 | $328.96M | ¥407.00 | -3.10% |
| Cabaletta Bio, Inc.NasdaqGS: CABA | $327.22M | $1.93 | -1.03% |
| Ocugen, Inc.NasdaqCM: OCGN | $324.02M | $0.96 | -2.24% |
| TWi Biotechnology, Inc.TPEX: 6610 | $322.75M | NT$50.20 | +11.43% |
| Cypherpunk Technologies Inc.NasdaqCM: CYPH | $316.83M | $2.94 | -2.97% |
| Medy-Tox Inc.KOSDAQ: A086900 | $316.58M | ₩65,900.00 | -1.05% |
| Orum Therapeutics, Inc.KOSDAQ: A475830 | $311.80M | ₩19,270.00 | -8.89% |
| Benitec Biopharma Inc.NasdaqCM: BNTC | $309.41M | $8.87 | -1.22% |
Figures last refreshed Oct 11, 2026.